Keyphrases
1p/19q Codeletion
15%
Antidepressants
17%
Apparent Diffusion Coefficient
17%
Astrocytes
23%
Astrocytoma
18%
Brain Metastases
22%
Brain Tumor
18%
Chromatin
15%
Chromatin Accessibility
23%
Chromatin Remodeling
15%
COVID-19
25%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
16%
EGFR Amplification
18%
Epigenetic Regulation
19%
Fluid-attenuated Inversion Recovery (FLAIR)
14%
Gene Expression
21%
Germinal Matrix
21%
Glia
17%
Glial Pathology
17%
Glioblastoma
100%
Glioblastoma Cells
14%
Glioma
83%
Glioma Model
20%
High-resolution
21%
Histone Modification
24%
Human Brain
35%
Human Temporal Lobe Epilepsy
17%
IDH mutation
20%
IDH-mutant Astrocytoma
25%
Immune Checkpoint Inhibitors
18%
Immunohistochemistry
14%
Isocitrate Dehydrogenase 1 (IDH1)
57%
Magnetic Resonance Imaging
16%
Molecular Diagnostics
17%
Myeloid Cells
20%
Pathophysiology
16%
Pituitary Adenoma
20%
Platelet-derived Growth Factor Receptor (PDGFR)
14%
Psychiatric Disorders
17%
Radiomics
15%
Recurrent Glioblastoma
19%
Resection
15%
Schizophrenia
15%
Single-cell Transcriptomics
20%
Tesla
17%
Transcriptomics
18%
Tumor
67%
Tumor Cells
20%
Type-specific
20%
Viral
15%
Medicine and Dentistry
Aggression
9%
Brain Metastasis
17%
Cancer
15%
Cell Population
9%
Cellular Infiltration
11%
Central Nervous System Tumor
9%
Chromosomal Instability
12%
COVID-19
17%
Diagnosis
12%
Disease Exacerbation
9%
Disease Marker
8%
DNA Methylation
9%
Epidermal Growth Factor Receptor
26%
Epigenomics
9%
Ethmoid Sinus
8%
Ganglioglioma
87%
Gene Expression Omnibus
8%
Genomic DNA
8%
Germinal Matrix
8%
Glioblastoma
58%
Histone
10%
Histone H3
8%
Hypohidrotic Ectodermal Dysplasia
8%
Immune Checkpoint Inhibitor
8%
Immunity
10%
Immunohistochemistry
21%
Infection
10%
Isocitrate Dehydrogenase
11%
Macrophage
11%
Magnetic Resonance Imaging
33%
Microglia
10%
Molecular Diagnosis
11%
Neoplasm
79%
Oligoastrocytoma
35%
Overall Survival
15%
Pathophysiology
8%
Pediatrics
11%
Pediatrics Patient
9%
Peripheral T-Cell Lymphoma
8%
Pituitary Adenoma
19%
Polymyositis
8%
Programmed Death-Ligand 1
9%
Progression Free Survival
9%
Prospective Study
11%
Radiomics
8%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Surgery
13%
T Cell
12%
Transcriptomics
11%
Tumor Progression
12%